June 06, 2019
Results from a first-in-man proof of concept study found occlusion of the superior vena cava (SVC) rapidly and effectively reduces pressure and volume in the heart. This is the first study targeting the SVC as a therapeutic area for heart failure patients to reduce cardiac filling pressures without reducing cardiac output or systemic blood pressure. Data is being presented as late-breaking clinical research at the Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions.
March 26, 2019
David Cox, MD, MSCAI, President of the Society for Cardiovascular Angiography and Interventions (SCAI), and Ron Waksman, MD, FSCAI, Director of MedStar Cardiovascular Research Network (MCRN) announced today at the Cardiovascular Research Technologies (CRT) 2019 meeting in Washington, DC a joint venture for MedStar to manage the data warehousing and analysis services for clinical, procedural, and outcomes data for SCAI’s quality improvement and research initiatives.
November 02, 2017
“This year, the Society for Cardiovascular Angiography and Interventions (SCAI) celebrated the forty-year anniversary of a groundbreaking procedure, now known as percutaneous coronary intervention (PCI), that has saved millions of lives and enhanced the lives of millions more.”
October 30, 2017
“The Society for Cardiovascular Angiography and Interventions announced today the launch of TRAnsition for VALUE, a multi-faceted educational initiative supported by Medtronic, to inform cardiologists, hospital administrators, and cath lab staff about the benefits of expanding the adoption of transradial (wrist access) percutaneous coronary intervention (PCI) in the U.S.”
May 12, 2017
“For patients who undergo transcatheter aortic valve replacement (TAVR), their risk factors, not the type of valve used, determined their 30-day post-TAVR outcomes.”
May 11, 2017
“More than one-third of patients undergoing transcatheter aortic valve replacement (TAVR) were observed to have atrial fibrillation (AF) either at baseline or new-onset within 30 days after TAVR.”
May 09, 2017
“Newly released recommendations for pediatric radiation safety will be discussed during the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans.”